Kamada-AAT for Inhalation

alpha-1 antitrypsin inhalation therapy · Kamada Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kamada-AAT for Inhalation, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation" [Phase 3]